Boston Scientific Group (BSX) May Gain Support Only Around $6.14

Boston Scientific Group (NYSE: BSX) has slipped to a trailing 52 week low of $6.79 by Monday mid-day trading, after a major gap-down opening. Boston Scientific Group (BSX) will now test its immediate support level of $6.14, which it formed early in last March.

With this, Boston Scientific Group (BSX) has already declined 13% to $6.79 on Monday itself, to record the biggest slide amongst the Standard & Poor’s 500 Index constituents. Boston Scientific Group (BSX), already trading in a bearish mode, had earlier suspended sales and implants of its line of implantable cardiac defibrillators because of a documentation error in its filings with the U.S. Food and Drug Administration (FDA).